Wyeth Launches Generic Protonix To Preempt Rivals
Teva was originally going to launch its generic product, pantoprazole, in December. However, it agreed not to ship the product while it tried to work out a deal with Altana, which makes Protonix, and Wyeth, which markets it in the U.S. Earlier this month, the agreement was extended to the end of January.
After the deal fell through, though, Wyeth...
To view the full article, register now.